D. Geadah

发表

Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats

J. Teitelbaum, Chantal Cossette, A. Gendron, 2002, Brain Research.

Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy

M. Leblanc, M. Ghannoum, S. Troyanov, 2004, Intensive Care Medicine.

Performance of the new plasma-compatible Advantage blood glucose test strips.

D. Geadah, M. Lebrun, A. Lane, 1997, Clinical biochemistry.

Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.

P. du Souich, V. Pichette, D. Geadah, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Transient Middle Cerebral Artery Occlusion Influence on Systemic Oxygen Homeostasis and Erythropoiesis in Wistar Rats

J. Teitelbaum, Chantal Cossette, P. du Souich, 2004, Stroke.

Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema.

J. Rouleau, N. Brown, A. Adam, 1999, Immunopharmacology.

Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction

J. Rouleau, A. Adam, C. Blais, 2001, Peptides.

Pharmacokinetics and pharmacodynamics of a slow‐release formulation of diltiazem after the administration of a single and repeated doses to healthy volunteers

D. Gossard, P. du Souich, Y. Lacasse, 1994, Biopharmaceutics & drug disposition.

Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters.

Daniel Parent, M. Leblanc, S. Troyanov, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates.

S. Brunet, Daniel Parent, M. Leblanc, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Folic acid and pyridoxal-5'-phosphate losses during high-efficiency hemodialysis in patients without hydrosoluble vitamin supplementation.

V. Pichette, M. Leblanc, D. Geadah, 2000, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis.

V. Pichette, A. Bonnardeaux, D. Geadah, 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

N-acetylprocainamide intoxication with torsade de pointes treated by high dialysate flow rate continuous arteriovenous hemodiafiltration.

V. Pichette, M. Leblanc, D. Geadah, 1995, Critical care medicine.

Serum concentrations and clearances of folic acid and pyridoxal-5′-phosphate during venovenous continuous renal replacement therapy

M. Leblanc, D. Geadah, Marie-Chantale Fortin, 1999, Intensive Care Medicine.

Lithium poisoning treated by high-performance continuous arteriovenous and venovenous hemodiafiltration.

J. Éthier, V. Pichette, M. Leblanc, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

High dialysate flow rate continuous arteriovenous hemodialysis: a new approach for the treatment of acute renal failure and tumor lysis syndrome.

V. Pichette, M. Leblanc, A. Bonnardeaux, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Myoglobin clearance and removal during continuous venovenous hemofiltration

M. Leblanc, D. Geadah, J. Cardinal, 1999, Intensive Care Medicine.

Influence of phenobarbital pretreatment on methoxyflurane and sodium fluoride nephropathy in Fischer 344 Rats.

J. Brodeur, D. Geadah, M. Côté, 1976, Toxicology and applied pharmacology.

The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit

V. Pichette, P. Souich, D. Geadah, 1996, British journal of pharmacology.

Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy.

L. Garred, V. Pichette, M. Leblanc, 1998, American Journal of Kidney Diseases.

Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.

R. Tremblay, L. Busque, M. Leblanc, 2000, Kidney international.

Prevention of methanol toxicity by ethanol therapy.

D. Geadah, J. Cardinal, R. Bergeron, 1982, The New England journal of medicine.

The use of an ethanol- and phosphate-enriched dialysate to maintain stable serum ethanol levels during haemodialysis for methanol intoxication.

M. Dorval, V. Pichette, M. Leblanc, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.